2023: A Year in Review
This year, I once again virtually sat down with Dr. David Kosub, from our communications group, to take a look back and to share some thoughts on what is to come for 2024.
This year, I once again virtually sat down with Dr. David Kosub, from our communications group, to take a look back and to share some thoughts on what is to come for 2024.
Whistleblowers help the government recoup funds and prevent additional wrongdoing. The HHS Office of Inspector General developed several video resources to help someone report wrongdoing related to a grant or contract, or even retaliation as a result of making such a report or filing a complaint.
1 Comments
The regulations and policies governing how we address research misconduct associated with NIH funding are being updated. Your thoughts on these proposed changes will help us continue making research integrity an utmost priority wherever NIH funded research is conducted. Comments may be submitted until December 5, 2023.
5 Comments
Assuming that biological or genetic differences relate directly to racial or ethnic categories can lead to false scientific conclusions and perpetuate bias. Misuse of population descriptors has harmed marginalized groups and promoted scientific racism. These limitations in existing population descriptors in genetics and genomics led 14 NIH Institutes, Centers, and Offices to sponsor the National Academies of Science, Engineering, and Medicine (NASEM) to establish an interdisciplinary committee of experts and explore the issue.
0 Comments
Sheila Garrity, JD, MPH, MBA, began as director of the HHS Office of Research Integrity (ORI) in March. As our offices work closely together to address research misconduct in NIH-funded biomedical research, we recently took some time to sit down and chat to get to know her better and welcome her to this new role.
4 Comments
We have seen rising numbers of allegations related to harassment, discrimination, and hostile work environments since 2018 (when we first started tracking them). In many cases, we successfully work with recipient institutions to put appropriate measures in place to address unsafe working environments. However, too often we hear from institutions that a PI has violated the institution’s policies and is no longer permitted to supervise students or staff, but there will be “no impact on NIH-funded work.” We have a problem with this response.
28 Comments
Effective for the May 2024 council round (peer review meetings in early 2024), all reviewers will be required to complete trainings related to review integrity and bias awareness prior to serving on NIH peer review groups. These trainings build on our long-standing commitment to maintaining integrity and fairness throughout the review process.
41 Comments
Reviewers are trusted and required to maintain confidentiality throughout the application review process. Thus, using AI to assist in peer review would involve a breach of confidentiality. In a recently released guide notice, we explain that NIH scientific peer reviewers are prohibited from using natural language processors, large language models, or other generative AI technologies for analyzing and formulating peer review critiques for grant applications and R&D contract proposals.
29 Comments
Today Science published our letter “Safeguarding integrity and collaborations,” which summarizes our perspectives on NIH efforts to address long-standing foreign interference threats, many stemming from foreign malign talent recruitment programs. We are grateful to Science for publishing our letter and for endorsing our efforts to “talk more openly.”
3 Comments
At the start of the year, we briefly touched on our efforts to address research integrity violations in our 2022 Year In Review. Today we are sharing some more information on the overall trends in research integrity allegations associated with the NIH grants process.
5 Comments
0 Comments